SPY756.10−0.49%QQQ684.00−0.92%BTC/USD73,497.75−0.58%DIA524.23−0.04%GLD365.88+0.19%TLT80.87−0.06%

American Healthcare REIT Inc

AHRNYSE

$59.17

-0.06-0.1%

Last update: Nov 11, 5:31 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Dividends Compare Options Stock Report

Earnings: Q3 2026 Earnings were released on Thu Nov 5th, after the market close

Conference Call: The most recent conference call started at 1:00 PM, 6 days ago

Click to view the webcast

American Healthcare REIT (AHR) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for American Healthcare REIT (AHR) stock.

Analyst Consensus — 16 Analysts

4S.Buy

11Buy

1Hold

# Analysts16

Latest Upgrades and Downgrades for American Healthcare REIT Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	UBS	Michael Goldsmith	PT Raise	Buy	$62→$71
—	Citigroup	Nick Joseph	PT Raise	Buy	$65→$67
—	RBC Capital	Michael Carroll	PT Raise	Outperform	$61→$66
—	UBS	Michael Goldsmith	PT Cut	Buy	$63→$62
—	Barclays	Richard Hightower	PT Cut	Overweight	$66→$60
—	Raymond James	David Rodgers	Initiate	Strong Buy	$62
—	Scotiabank	Nicholas Yulico	PT Raise	Sector Outperform	$56→$62
—	Barclays	Richard Hightower	PT Raise	Overweight	$61→$66
—	Keybanc	Austin Wurschmidt	PT Raise	Overweight	$58→$68
—	Truist Securities	Michael Lewis	PT Raise	Buy	$57→$61
—	RBC Capital	Michael Carroll	PT Raise	Outperform	$56→$61
—	Citigroup	Nick Joseph	PT Raise	Buy	$55→$65
—	Citizens	Aaron Hecht	PT Raise	Market Outperform	$60→$65
—	Compass Point	Rob Simone	Initiate	Buy	$70
—	UBS	Michael Goldsmith	PT Raise	Buy	$60→$63
—	Barclays	Richard Hightower	Initiate	Overweight	$61
—	Citigroup	Nick Joseph	Upgrade	Neutral→Buy	$55
—	Scotiabank	Nicholas Yulico	PT Cut	Sector Outperform	$59→$51
—	Keybanc	Austin Wurschmidt	PT Raise	Overweight	$55→$58
—	RBC Capital	Michael Carroll	PT Raise	Outperform	$54→$56

American Healthcare REIT Inc

American Healthcare REIT (AHR) Stock Price Target 2026

Latest Upgrades and Downgrades for American Healthcare REIT Stock

American Healthcare REIT (AHR) Stock Price Target 2026

Latest Upgrades and Downgrades for American Healthcare REIT Stock

Analyst Ratings News

PRO
UBS Maintains Buy on American Healthcare REIT, Raises Price Target to $71

PRO
Citigroup Maintains Buy on American Healthcare REIT, Raises Price Target to $67

PRO
RBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $66

PRO
UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

People Also Watch

People Also Watch

Analyst Ratings News

PRO
UBS Maintains Buy on American Healthcare REIT, Raises Price Target to $71

PRO
Citigroup Maintains Buy on American Healthcare REIT, Raises Price Target to $67

PRO
RBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $66

PRO
UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

American Healthcare REIT Inc

American Healthcare REIT (AHR) Stock Price Target 2026

Latest Upgrades and Downgrades for American Healthcare REIT Stock

American Healthcare REIT (AHR) Stock Price Target 2026

Latest Upgrades and Downgrades for American Healthcare REIT Stock

Analyst Ratings News

PROUBS Maintains Buy on American Healthcare REIT, Raises Price Target to $71

PROCitigroup Maintains Buy on American Healthcare REIT, Raises Price Target to $67

PRORBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $66

PROUBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

PROBarclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

People Also Watch

People Also Watch

Analyst Ratings News

PROUBS Maintains Buy on American Healthcare REIT, Raises Price Target to $71

PROCitigroup Maintains Buy on American Healthcare REIT, Raises Price Target to $67

PRORBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $66

PROUBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

PROBarclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

PRO
UBS Maintains Buy on American Healthcare REIT, Raises Price Target to $71

PRO
Citigroup Maintains Buy on American Healthcare REIT, Raises Price Target to $67

PRO
RBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $66

PRO
UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

PRO
UBS Maintains Buy on American Healthcare REIT, Raises Price Target to $71

PRO
Citigroup Maintains Buy on American Healthcare REIT, Raises Price Target to $67

PRO
RBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $66

PRO
UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60